Literature DB >> 16041552

Modified radical lymphadenectomy (D1.5) for T2-3 gastric cancer.

Takashi Ichikura1, Kentaro Chochi, Hidekazu Sugasawa, Hidetaka Mochizuki.   

Abstract

BACKGROUND: The operative mortality in gastric cancer surgery has been reported to be higher with D2 lymphadenectomy than with D1 in the West. The modified radical lymphadenectomy (D1.5) may be safer than D2 under these circumstances. This study was aimed to determine whether D1.5 would deteriorate long-term survival as compared with D2.
METHOD: Since the concept of the extent of lymphadenectomy varied among the surgeons, 461 patients who underwent curative gastrectomy for T2-4 gastric adenocarcinoma were retrospectively categorized into three groups according to the surgeon: D1 with dissection along the left gastric and common hepatic arteries (D1.5); lymphadenectomy between D1.5 and D2; D2 or more extended dissection.
RESULTS: No differences were found in the survival rates among the three groups within each of the T2a, T2b, and T3 categories. According to a multivariate analysis using Cox's proportional hazard model, the classification according to the surgeons had no survival impact (p>0.8).
CONCLUSION: D1.5 lymphadenectomy resulted in a survival rate that was almost equal to that of D2. The use of D1.5 instead of D2 can be an attractive option to be compared with D1 in future trials.

Entities:  

Mesh:

Year:  2005        PMID: 16041552     DOI: 10.1007/s00423-005-0570-7

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  29 in total

1.  Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer.

Authors:  Erhan Reis; Nuri Aydin Kama; Mutlu Doganay; Mesut Atli; Mete Dolapci
Journal:  Hepatogastroenterology       Date:  2002 Jul-Aug

2.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

Authors:  A Cuschieri; P Fayers; J Fielding; J Craven; J Bancewicz; V Joypaul; P Cook
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

3.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

4.  Improved physical condition by limiting lymphadenectomy around the coeliac artery after distal gastrectomy for gastric cancer.

Authors:  T Ichikura; S Tomimatsu; Y Okusa; H Mochizuki
Journal:  Eur J Surg       Date:  1999-02

5.  An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution.

Authors:  Yuichi Kasakura; Fumiro Mochizuki; Kazuhiko Wakabayashi; Mitsugu Kochi; Masashi Fujii; Tadatoshi Takayama
Journal:  J Surg Res       Date:  2002-04       Impact factor: 2.192

6.  Gastric cancer: which patients benefit from systematic lymphadenectomy?

Authors:  N M Bösing; P E Goretzki; H D Röher
Journal:  Eur J Surg Oncol       Date:  2000-08       Impact factor: 4.424

7.  Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.

Authors:  Takeshi Sano; Mitsuru Sasako; Seiichiro Yamamoto; Atsushi Nashimoto; Akira Kurita; Masahiro Hiratsuka; Toshimasa Tsujinaka; Taira Kinoshita; Kuniyoshi Arai; Yoshitaka Yamamura; Kunio Okajima
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

8.  Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

Authors:  A Cuschieri; S Weeden; J Fielding; J Bancewicz; J Craven; V Joypaul; M Sydes; P Fayers
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

9.  Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer.

Authors:  L E Harrison; M S Karpeh; M F Brennan
Journal:  J Gastrointest Surg       Date:  1998 Mar-Apr       Impact factor: 3.267

10.  Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma.

Authors:  P Edwards; G R J C Blackshaw; W G Lewis; J D Barry; M C Allison; D R B Jones
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

View more
  10 in total

1.  Laparoscopic-assisted distal gastrectomy versus open distal gastrectomy for advanced gastric cancer.

Authors:  Sang Il Hwang; Hyung Ook Kim; Chang Hak Yoo; Jun Ho Shin; Byung Ho Son
Journal:  Surg Endosc       Date:  2008-10-15       Impact factor: 4.584

2.  Reoperation for early postoperative complications after gastric cancer surgery in a Chinese hospital.

Authors:  Birendra Kumar Sah; Ming-Min Chen; Min Yan; Zheng-Gang Zhu
Journal:  World J Gastroenterol       Date:  2010-01-07       Impact factor: 5.742

3.  Laparoscopic Gastric Resection for Gastric Cancer: Is Intracorporeal Anastomosis Necessary?

Authors:  Ersen Ogun; Unal Ali Ekrem; Cemil Yuksel; Culcu Serdar; Salim Ilksen Basceken; Mercan Umit; Demirci Salim
Journal:  Pak J Med Sci       Date:  2020 Sep-Oct       Impact factor: 1.088

4.  Impact of obesity on early surgical and oncologic outcomes after total gastrectomy with "over-D1" lymphadenectomy for gastric cancer.

Authors:  Giacomo Pata; Leonardo Solaini; Stefano Roncali; Mario Pasini; Fulvio Ragni
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

5.  The node ratio as prognostic factor after curative resection for gastric cancer.

Authors:  Mario Sianesi; Lamia Bezer; Paolo Del Rio; Paolo Dell'Abate; Gioacchino Iapichino; Paolo Soliani; Sara Tacci
Journal:  J Gastrointest Surg       Date:  2010-01-26       Impact factor: 3.452

6.  Satisfactory surgical outcome of T2 gastric cancer after modified D2 lymphadenectomy.

Authors:  Shupeng Zhang; Liangliang Wu; Xiaona Wang; Xuewei Ding; Han Liang
Journal:  Chin J Cancer Res       Date:  2017-04       Impact factor: 5.087

7.  Post-operative complications of gastric cancer surgery: female gender at high risk.

Authors:  B K Sah; Z G Zhu; X Y Wang; Q M Yang; M M Chen; M Xiang; J Chen; M Yan
Journal:  Eur J Cancer Care (Engl)       Date:  2009-03       Impact factor: 2.520

8.  Gastric cancer surgery: Billroth I or Billroth II for distal gastrectomy?

Authors:  Birendra K Sah; Ming-Min Chen; Min Yan; Zheng-Gang Zhu
Journal:  BMC Cancer       Date:  2009-12-09       Impact factor: 4.430

9.  The survival benefit and safety of No. 12a lymphadenectomy for gastric cancer patients with distal or total gastrectomy.

Authors:  Kun Yang; Hai-Ning Chen; Kai Liu; Wei-Han Zhang; Xin-Zu Chen; Xiao-Long Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Oncotarget       Date:  2016-04-05

10.  Risk of station 12a lymph node metastasis in patients with lower-third gastric cancer.

Authors:  Yin-Ping Dong; Feng-Lin Cai; Zi-Zhen Wu; Peng-Liang Wang; Yang Yang; Shi-Wei Guo; Zhen-Zhen Zhao; Fu-Cheng Zhao; Han Liang; Jing-Yu Deng
Journal:  World J Gastrointest Surg       Date:  2021-11-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.